Smoking and Behçet Disease May Increase Tuberculosis Risk in Systemic Vasculitis
-
Vagus Nerve Stimulation for Rheumatoid Arthritis: Trial Results and Future DirectionsWe spoke with Mark Richardson, MD, PhD, and John Tesser, MD, to discuss vagus nerve stimulation for the treatment RA and results of the pivotal RESET-RA trial.
-
Frailty in Rheumatology: An Emerging – and Potentially Reversible – Risk FactorJ Eugene Huffstutter, MD, and Robert G Hylland, MD, discuss the evolving concept of frailty in rheumatology.
-
What We Know — and Don’t Know — About Difficult-to-Treat Rheumatoid ArthritisThe exact definition of difficult-to-treat rheumatoid arthritis has been the subject of debate due to the heterogeneous patient population.
-
Digital Therapeutics Set to Transform Pain Management in Rheumatic DiseaseIn part 2 of this series, Swamy Venuturupalli, MD, and Beth Darnall, PhD, discuss the current research on the use of digital therapeutics for managing chronic pain.
-
Pandemic Expansion of Medicare Telehealth Coverage Set to End March 31Over the past 5 years, telehealth has grown from an emergency stopgap during the COVID-19 pandemic to a cornerstone of modern health care. Whether for routine check-ups, mental health counseling, or chronic disease management, telehealth has bridged the gap for patients who might otherwise struggle to access care — due to immunocompromise, mobility challenges, geographic…
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
- Axial Spondyloarthritis
- Connective Tissue Disease
- Crystal Arthropathies
- Diseases of Bone and Cartilage
- General Medicine
- General Rheumatology
- Infection in Rheumatic Disease
- Musculoskeletal Pain
- Myositis
- Osteoarthritis
- Pediatric Rheumatology
- Practice Management
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Sjögren Syndrome
- Systemic Lupus Erythematosus
- Vasculitis